Balyasny Asset Management »

Bridgebio Pharma shares owned by Balyasny Asset Management

Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Balyasny Asset Management from 13F filings

Historical chart of Balyasny Asset Management investment in Bridgebio Pharma

Tip: Access up to 7 years of quarterly data

All positions including Bridgebio Pharma held by Balyasny Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bridgebio Pharma by Balyasny Asset Management

Quarter filed Position value Share count Share price at filing
2024-06-30 $5.3M 207k 25.33
2023-03-31 $3.6M 220k 16.58
2022-09-30 $249k 25k 9.96
2022-03-31 $373k 37k 10.14
2021-12-31 $812k 49k 16.67
2020-12-31 $3.6M 50k 71.12

More positions owned by Balyasny Asset Management

Ishares Tr Russell 2000 Etf (IWM)
Apple Call Option (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Select Sector Spdr Tr Financial (XLF)
Microsoft Corporation Call Option (MSFT)
Amazon Call Option (AMZN)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Core S&p Mcp Etf (IJH)
Vanguard Index Fds Total Stk Mkt (VTI)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Mastercard Incorporated Cl A Call Option (MA)
Hess Call Option (HES)
Lockheed Martin Corporation Call Option (LMT)
Endeavor Group Hldgs Cl A Com Put Option (EDR)

View all positions for Balyasny Asset Management

Top funds holding Bridgebio Pharma

Kohlberg Kravis Roberts & Co
Viking Global Investors
Vanguard Group
BlackRock
BlackRock
Aisling Capital Management
State Street Corporation
Susquehanna International
Henderson Group
Laurion Capital Management
Frazier Life Sciences Management
Geode Capital Management
Citadel Advisors
Pictet Asset Management Holding SA
Jane Street

View all funds holding Bridgebio Pharma